SciClone Pharmaceuticals, Inc. Tumbles on SEC Investigation, U.S. DOJ FCPA Compliance Issues

Street Insider -- Shares of SciClone (Nasdaq: SCLN) are taking a tumble this morning as the company reported that they have been contacted by the U.S. SEC for an investigation. Shares are down 31% to $2.40 in the morning session.